Hypogonadal Men Nonresponders to the PDE5 Inhibitor Tadalafil Benefit from Normalization of Testosterone Levels with a 1% Hydroalcoholic Testosterone Gel in the Treatment of Erectile Dysfunction (TADTEST Study)-Reference-Cited by-同舟云学术

Hypogonadal Men Nonresponders to the PDE5 Inhibitor Tadalafil Benefit from Normalization of Testosterone Levels with a 1% Hydroalcoholic Testosterone Gel in the Treatment of Erectile Dysfunction (TADTEST Study)

Published:2011-01 Issue:1 Volume:8 Page:284-293
ISSN:1743-6095
Container-title:The Journal of Sexual Medicine
language:en
Short-container-title:The Journal of Sexual Medicine

Author:

Buvat Jacques,Montorsi Francesco,Maggi Mario,Porst Hartmut,Kaipia Antti,Colson Marie Helène,Cuzin Beatrice,Moncada Ignacio,Martin‐Morales Antonio,Yassin Aksam,Meuleman Eric,Eardley Ian,Dean John Daniel,Shabsigh Ridwan

Publisher

Elsevier BV

Subject

Urology,Reproductive Medicine,Endocrinology,Endocrinology, Diabetes and Metabolism,Psychiatry and Mental health

Reference32 articles.

1. Combination therapy with phosphodiesterase type V inhibitors and testosterone.;Buvat;Current Sexual Health Reports,2008

2. Effects of castration and androgen replacement on erectile function in a rabbit model;Traish;Endocrinology,1999

3. Androgens regulate phosphodiesterase type 5 expression and functional activity in corpora cavernosa;Morelli;Endocrinology,2004

4. Testosterone regulates PDE5 expression and in vivo responsiveness to tadalafil in rat corpus cavernosum;Zhang;Eur Urol,2005

5. Testosterone partially ameliorates metabolic profile and erectile responsiveness to PDE5 inhibitors in an animal model of male metabolic syndrome;Filippi;J Sex Med,2009

Cited by 141 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Erectile Dysfunction in Patients Treated with Selpercatinib for RET-Altered Thyroid Cancer;Thyroid®;2024-07-19

2. ROUX-en-Y gastric bypass surgery improves metabolic syndrome–related erectile dysfunction in mice via the IRS-1/PI3K/AKT/eNOS pathway;Sexual Medicine;2024-03-27

3. Testosterone replacement in men with sexual dysfunction;Cochrane Database of Systematic Reviews;2024-01-15

4. Princeton IV consensus guidelines: PDE5 inhibitors and cardiac health;The Journal of Sexual Medicine;2023-12-26

5. Efficacy and safety of PDE5 inhibitors in middle-aged and old patients with and without hypogonadism;The Aging Male;2023-12-26